FMP
LakeShore Biopharma Co., Ltd.
LSBPW
NASDAQ
LakeShore Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
0.0546 USD
0.0186 (34.07%)
About
Description
LakeShore Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
CIK
0001946399
ISIN
N/A
CUSIP
N/A
Address
Building No. 2
Phone
86 10 8920 2086
Country
CN
Employee
758
IPO Date
N/A
Key Executives
Name
Title
Pay
Year Born
Dr. Zenaida Reynoso Mojares M.D.
Chief Medical Officer
0
1959
Dr. Yuan Liu Ph.D.
Head of Vaccine Research
0
1987
Mr. Wang Xu
Chief Executive Officer & Director
0
1971
Ms. Rui Yu M.B.A., M.S.
Chief Financial Officer & Director
0
1975
Ms. Zhiyuan Ran
Head of Medical & Marketing Department
0
N/A
Dr. Hui Shao C.F.A., M.B.A., Ph.D.
President, Chief Business Officer & Vice...
0
1968
As of December 31, 2024, the total employee count stands at 758, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.
